A neutral, evidence-rated side-by-side of Oxandrolone and Stanozolol (Winstrol). Figures are typical reference values, not recommendations.
| Oxandrolone | Stanozolol (Winstrol) | |
|---|---|---|
| Type | Anabolic steroid | Anabolic steroid |
| Evidence level | Well established | Studied |
| Primary class | Androgen | Androgen |
| Half-life | ~9 hours | ~9 hours (oral) |
| Typical dose | 20–50 mg/day | 20–50 mg/day |
| Anabolic : androgenic | 322 : 24 | 320 : 30 |
| Aromatises | No | No |
| Hepatotoxicity | Moderate | Moderate |
| HPTA suppression | Moderate | Severe |
| Documented effects | 3 | 3 |
| Documented side effects | 2 | 3 |
A mild oral DHT-derived steroid with a genuine clinical history in burns and wasting. Popular for strength and definition without water retention — with a worse lipid profile than its gentle reputation suggests.
Full Oxandrolone page →Stanozolol ('Winstrol', 'Winny') is a 17α-methylated DHT-derived steroid with a fused pyrazole ring, available orally and as an aqueous injectable. It does not aromatise and produces a dry, hardened look with strength gains rather than mass, making it a classic cutting and athletic-performance compound. It notably lowers HDL, strains the liver and is associated with joint discomfort.
Full Stanozolol (Winstrol) page →